Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2067082678', 'doi': 'https://doi.org/10.1097/00006982-200512000-00026', 'title': 'A CONVENIENT METHOD TO CONCENTRATE TRIAMCINOLONE ACETONIDE FOR INTRAVITREAL INJECTION', 'display_name': 'A CONVENIENT METHOD TO CONCENTRATE TRIAMCINOLONE ACETONIDE FOR INTRAVITREAL INJECTION', 'publication_year': 2005, 'publication_date': '2005-12-01', 'ids': {'openalex': 'https://openalex.org/W2067082678', 'doi': 'https://doi.org/10.1097/00006982-200512000-00026', 'mag': '2067082678', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/16340548'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1097/00006982-200512000-00026', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S19572933', 'display_name': 'Retina', 'issn_l': '0275-004X', 'issn': ['0275-004X', '1539-2864'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5061389530', 'display_name': 'Hee Seung Chin', 'orcid': 'https://orcid.org/0000-0003-2104-3504'}, 'institutions': [{'id': 'https://openalex.org/I4210153373', 'display_name': 'Inha University Hospital', 'ror': 'https://ror.org/04gj5px28', 'country_code': 'KR', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210153373']}], 'countries': ['KR'], 'is_corresponding': False, 'raw_author_name': 'HEE SEUNG CHIN', 'raw_affiliation_strings': ['From the Department of Ophthalmology, Inha University Hospital, Incheon, South Korea.', 'RETINA®, The Journal of Retinal and Vitreous Diseases, encourages authors to submit Brief Reports describing unusual findings, new techniques, and new instruments. Material submitted for consideration in this section of the journal is done so with the assumption that the data provided do not duplicate previously published material and that the material has not been submitted for consideration elsewhere. Each author must sign a disclosure to this effect (see Instructions to Authors for complete wording of transfer letter). Brief Reports submitted for this section of the journal may be subjected to the standard review process that is applied to other material submitted to RETINA®. Brief Reports should follow the requirements listed in the Instructions to Authors, with the following caveats: Brief Reports should not exceed 4 pages in length', 'each Brief Report should include no more than 4 figures.', 'no more than 5 references should be cited'], 'affiliations': [{'raw_affiliation_string': 'From the Department of Ophthalmology, Inha University Hospital, Incheon, South Korea.', 'institution_ids': ['https://openalex.org/I4210153373']}, {'raw_affiliation_string': 'RETINA®, The Journal of Retinal and Vitreous Diseases, encourages authors to submit Brief Reports describing unusual findings, new techniques, and new instruments. Material submitted for consideration in this section of the journal is done so with the assumption that the data provided do not duplicate previously published material and that the material has not been submitted for consideration elsewhere. Each author must sign a disclosure to this effect (see Instructions to Authors for complete wording of transfer letter). Brief Reports submitted for this section of the journal may be subjected to the standard review process that is applied to other material submitted to RETINA®. Brief Reports should follow the requirements listed in the Instructions to Authors, with the following caveats: Brief Reports should not exceed 4 pages in length', 'institution_ids': []}, {'raw_affiliation_string': 'no more than 5 references should be cited', 'institution_ids': []}, {'raw_affiliation_string': 'each Brief Report should include no more than 4 figures.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5100434365', 'display_name': 'Tae‐Hwan Kim', 'orcid': 'https://orcid.org/0000-0002-3542-2276'}, 'institutions': [{'id': 'https://openalex.org/I4210153373', 'display_name': 'Inha University Hospital', 'ror': 'https://ror.org/04gj5px28', 'country_code': 'KR', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210153373']}], 'countries': ['KR'], 'is_corresponding': False, 'raw_author_name': 'TAE HWAN KIM', 'raw_affiliation_strings': ['From the Department of Ophthalmology, Inha University Hospital, Incheon, South Korea.', 'RETINA®, The Journal of Retinal and Vitreous Diseases, encourages authors to submit Brief Reports describing unusual findings, new techniques, and new instruments. Material submitted for consideration in this section of the journal is done so with the assumption that the data provided do not duplicate previously published material and that the material has not been submitted for consideration elsewhere. Each author must sign a disclosure to this effect (see Instructions to Authors for complete wording of transfer letter). Brief Reports submitted for this section of the journal may be subjected to the standard review process that is applied to other material submitted to RETINA®. Brief Reports should follow the requirements listed in the Instructions to Authors, with the following caveats: Brief Reports should not exceed 4 pages in length', 'each Brief Report should include no more than 4 figures.', 'no more than 5 references should be cited'], 'affiliations': [{'raw_affiliation_string': 'RETINA®, The Journal of Retinal and Vitreous Diseases, encourages authors to submit Brief Reports describing unusual findings, new techniques, and new instruments. Material submitted for consideration in this section of the journal is done so with the assumption that the data provided do not duplicate previously published material and that the material has not been submitted for consideration elsewhere. Each author must sign a disclosure to this effect (see Instructions to Authors for complete wording of transfer letter). Brief Reports submitted for this section of the journal may be subjected to the standard review process that is applied to other material submitted to RETINA®. Brief Reports should follow the requirements listed in the Instructions to Authors, with the following caveats: Brief Reports should not exceed 4 pages in length', 'institution_ids': []}, {'raw_affiliation_string': 'no more than 5 references should be cited', 'institution_ids': []}, {'raw_affiliation_string': 'each Brief Report should include no more than 4 figures.', 'institution_ids': []}, {'raw_affiliation_string': 'From the Department of Ophthalmology, Inha University Hospital, Incheon, South Korea.', 'institution_ids': ['https://openalex.org/I4210153373']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5110170713', 'display_name': 'Yeon Sung Moon', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210153373', 'display_name': 'Inha University Hospital', 'ror': 'https://ror.org/04gj5px28', 'country_code': 'KR', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210153373']}], 'countries': ['KR'], 'is_corresponding': False, 'raw_author_name': 'YEON SUNG MOON', 'raw_affiliation_strings': ['From the Department of Ophthalmology, Inha University Hospital, Incheon, South Korea.', 'RETINA®, The Journal of Retinal and Vitreous Diseases, encourages authors to submit Brief Reports describing unusual findings, new techniques, and new instruments. Material submitted for consideration in this section of the journal is done so with the assumption that the data provided do not duplicate previously published material and that the material has not been submitted for consideration elsewhere. Each author must sign a disclosure to this effect (see Instructions to Authors for complete wording of transfer letter). Brief Reports submitted for this section of the journal may be subjected to the standard review process that is applied to other material submitted to RETINA®. Brief Reports should follow the requirements listed in the Instructions to Authors, with the following caveats: Brief Reports should not exceed 4 pages in length', 'each Brief Report should include no more than 4 figures.', 'no more than 5 references should be cited'], 'affiliations': [{'raw_affiliation_string': 'RETINA®, The Journal of Retinal and Vitreous Diseases, encourages authors to submit Brief Reports describing unusual findings, new techniques, and new instruments. Material submitted for consideration in this section of the journal is done so with the assumption that the data provided do not duplicate previously published material and that the material has not been submitted for consideration elsewhere. Each author must sign a disclosure to this effect (see Instructions to Authors for complete wording of transfer letter). Brief Reports submitted for this section of the journal may be subjected to the standard review process that is applied to other material submitted to RETINA®. Brief Reports should follow the requirements listed in the Instructions to Authors, with the following caveats: Brief Reports should not exceed 4 pages in length', 'institution_ids': []}, {'raw_affiliation_string': 'no more than 5 references should be cited', 'institution_ids': []}, {'raw_affiliation_string': 'each Brief Report should include no more than 4 figures.', 'institution_ids': []}, {'raw_affiliation_string': 'From the Department of Ophthalmology, Inha University Hospital, Incheon, South Korea.', 'institution_ids': ['https://openalex.org/I4210153373']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5101054853', 'display_name': 'Jung Hyub Oh', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210153373', 'display_name': 'Inha University Hospital', 'ror': 'https://ror.org/04gj5px28', 'country_code': 'KR', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210153373']}], 'countries': ['KR'], 'is_corresponding': False, 'raw_author_name': 'JUNG HYUB OH', 'raw_affiliation_strings': ['From the Department of Ophthalmology, Inha University Hospital, Incheon, South Korea.', 'RETINA®, The Journal of Retinal and Vitreous Diseases, encourages authors to submit Brief Reports describing unusual findings, new techniques, and new instruments. Material submitted for consideration in this section of the journal is done so with the assumption that the data provided do not duplicate previously published material and that the material has not been submitted for consideration elsewhere. Each author must sign a disclosure to this effect (see Instructions to Authors for complete wording of transfer letter). Brief Reports submitted for this section of the journal may be subjected to the standard review process that is applied to other material submitted to RETINA®. Brief Reports should follow the requirements listed in the Instructions to Authors, with the following caveats: Brief Reports should not exceed 4 pages in length', 'each Brief Report should include no more than 4 figures.', 'no more than 5 references should be cited'], 'affiliations': [{'raw_affiliation_string': 'RETINA®, The Journal of Retinal and Vitreous Diseases, encourages authors to submit Brief Reports describing unusual findings, new techniques, and new instruments. Material submitted for consideration in this section of the journal is done so with the assumption that the data provided do not duplicate previously published material and that the material has not been submitted for consideration elsewhere. Each author must sign a disclosure to this effect (see Instructions to Authors for complete wording of transfer letter). Brief Reports submitted for this section of the journal may be subjected to the standard review process that is applied to other material submitted to RETINA®. Brief Reports should follow the requirements listed in the Instructions to Authors, with the following caveats: Brief Reports should not exceed 4 pages in length', 'institution_ids': []}, {'raw_affiliation_string': 'no more than 5 references should be cited', 'institution_ids': []}, {'raw_affiliation_string': 'each Brief Report should include no more than 4 figures.', 'institution_ids': []}, {'raw_affiliation_string': 'From the Department of Ophthalmology, Inha University Hospital, Incheon, South Korea.', 'institution_ids': ['https://openalex.org/I4210153373']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 2.6, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 11, 'citation_normalized_percentile': {'value': 0.689518, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 82, 'max': 83}, 'biblio': {'volume': '25', 'issue': '8', 'first_page': '1107', 'last_page': '1108'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11826', 'display_name': 'Ocular Infections and Treatments', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/2731', 'display_name': 'Ophthalmology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11826', 'display_name': 'Ocular Infections and Treatments', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/2731', 'display_name': 'Ophthalmology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12599', 'display_name': 'Retinal and Optic Conditions', 'score': 0.9996, 'subfield': {'id': 'https://openalex.org/subfields/2731', 'display_name': 'Ophthalmology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11194', 'display_name': 'Ocular Diseases and Behçet’s Syndrome', 'score': 0.9996, 'subfield': {'id': 'https://openalex.org/subfields/2731', 'display_name': 'Ophthalmology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/acetonide', 'display_name': 'Acetonide', 'score': 0.5917327}], 'concepts': [{'id': 'https://openalex.org/C2778903070', 'wikidata': 'https://www.wikidata.org/wiki/Q2211240', 'display_name': 'Triamcinolone acetonide', 'level': 2, 'score': 0.8482509}, {'id': 'https://openalex.org/C2776251621', 'wikidata': 'https://www.wikidata.org/wiki/Q4673280', 'display_name': 'Acetonide', 'level': 3, 'score': 0.5917327}, {'id': 'https://openalex.org/C118487528', 'wikidata': 'https://www.wikidata.org/wiki/Q161437', 'display_name': 'Ophthalmology', 'level': 1, 'score': 0.50042415}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.4106148}], 'mesh': [{'descriptor_ui': 'D005938', 'descriptor_name': 'Glucocorticoids', 'qualifier_ui': 'Q000737', 'qualifier_name': 'chemistry', 'is_major_topic': True}, {'descriptor_ui': 'D004364', 'descriptor_name': 'Pharmaceutical Preparations', 'qualifier_ui': 'Q000737', 'qualifier_name': 'chemistry', 'is_major_topic': True}, {'descriptor_ui': 'D014222', 'descriptor_name': 'Triamcinolone Acetonide', 'qualifier_ui': 'Q000737', 'qualifier_name': 'chemistry', 'is_major_topic': True}, {'descriptor_ui': 'D005938', 'descriptor_name': 'Glucocorticoids', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007267', 'descriptor_name': 'Injections', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004364', 'descriptor_name': 'Pharmaceutical Preparations', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014222', 'descriptor_name': 'Triamcinolone Acetonide', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014822', 'descriptor_name': 'Vitreous Body', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1097/00006982-200512000-00026', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S19572933', 'display_name': 'Retina', 'issn_l': '0275-004X', 'issn': ['0275-004X', '1539-2864'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/16340548', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.6, 'display_name': 'Zero hunger', 'id': 'https://metadata.un.org/sdg/2'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 6, 'referenced_works': ['https://openalex.org/W11282075', 'https://openalex.org/W2064353444', 'https://openalex.org/W2083092631', 'https://openalex.org/W2146755607', 'https://openalex.org/W2159723361', 'https://openalex.org/W2546961712'], 'related_works': ['https://openalex.org/W3032200851', 'https://openalex.org/W2367705216', 'https://openalex.org/W2316413395', 'https://openalex.org/W2232176731', 'https://openalex.org/W2049217030', 'https://openalex.org/W2046241139', 'https://openalex.org/W2017732084', 'https://openalex.org/W2001733471', 'https://openalex.org/W1991769640', 'https://openalex.org/W1965989520'], 'abstract_inverted_index': {'CHIN,': [0], 'HEE': [1], 'SEUNG': [2], 'MD;': [3, 7, 11], 'KIM,': [4], 'TAE': [5], 'HWAN': [6], 'MOON,': [8], 'YEON': [9], 'SUNG': [10], 'OH,': [12], 'JUNG': [13], 'HYUB': [14], 'MD': [15], 'Author': [16], 'Information': [17]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2067082678', 'counts_by_year': [{'year': 2023, 'cited_by_count': 1}, {'year': 2020, 'cited_by_count': 1}], 'updated_date': '2024-12-17T15:13:22.773663', 'created_date': '2016-06-24'}